Detalles de la búsqueda
1.
Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048.
Oral Oncol
; 128: 105815, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35381576
2.
Health-Related Quality of Life of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma Treated with Pembrolizumab in KEYNOTE-629.
Dermatol Ther (Heidelb)
; 11(5): 1777-1790, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34558040
Resultados
1 -
2
de 2
1
Próxima >
>>